Latest Breaking News On - Treatment resistant depression - Page 9 : vimarsana.com

Protagenic Therapeutics Achieves First Clinical Safety Milestone with

Protagenic Therapeutics Achieves First Clinical Safety Milestone with .

New yorkUnited statesRobertb steinCompany perspectiveProtagenic therapeutics incNews networkCompany contactAdvisory incProtagenic therapeuticsClinical protocol progressTreatment resistant depressionGeneralized anxietyComprehensive approachStrategic collaborationAxiom real time metricsData analytics

Protagenic Therapeutics, Inc : Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

Protagenic Therapeutics, Inc : Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesStefan klotterRobertb steinAdvisory incCompany contactProtagenic therapeutics incCompany perspectiveProtagenic therapeuticsProtocol progressTreatment resistant depressionGeneralized anxietyAxiom real time metricsData analyticsMaurizio favaPrincipal investigator

Clerkenwell Health: Trial of new psychedelic drug seeks patients with Treatment Resistant Depression

Clerkenwell Health: Trial of new psychedelic drug seeks patients with Treatment Resistant Depression
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofUnited statesRob conleyStefan klotterHenry fisherBeckley psytechBeckley psytechtoClerkenwell healthTreatment resistant depressionHarley streetChief scientific officerTreatment resistantChief medicalScientific officerDie performance strategie

Trial of new psychedelic drug seeks patients with Treatment

London, Feb. 07, 2024 (GLOBE NEWSWIRE) An international clinical trial which is investigating a novel synthetic formulation of the psychedelic.

United kingdomCity ofUnited statesHenry fisherRob conleyBeckley psytechClerkenwell healthTreatment resistant depressionHarley streetChief scientific officerTreatment resistantChief medicalScientific officerMental health treatmentPsychedelic drug trialTreatment resistant depression

Ketamine infusions effective for treating depression, veterans study shows

Researchers say that almost half of 215 veterans who'd been suffering severe, treatment-resistant depression benefited from six weeks of ketamine infusions.

Ann arborUnited statesPaul pfeifferAvinash hosanagarSchool departmentDrug administrationUniversity of michiganHarbor healthcare systemUm medical schoolTreatment resistant depressionVa ann arbor healthcare systemPaul pfeifferKetamine infusionsParty drug ketamineKetamine treatment